Passage BIO PASG
NASDAQ PASG
$4.00 +0.22 (+5.82%)
At close: Nov 11, 2026 · 4:00 PM EST

Passage BIO (PASG) Share-based Compensation (IS) (2024 - 2026)

Updated

Analysis

Passage BIO (PASG) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Passage BIO 12.16 Mn -111.84 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3,000.00
Jun 30, 2026 49,000.00
Mar 31, 2026 142,000.00
Dec 31, 2025 180,000.00
Sep 30, 2025 170,000.00
Jun 30, 2025 248,000.00
Mar 31, 2025 244,000.00
Dec 31, 2024 451,000.00
Sep 30, 2024 535,000.00
Jun 30, 2024 725,000.00
Mar 31, 2024 818,000.00
API Access

Passage BIO Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PASG&period=max&api_key=YOUR_API_KEY